Lipopeptide-based pan-CoV fusion inhibitors potently inhibit HIV-1 infection

Microbes Infect. 2021 Sep-Oct;23(8):104840. doi: 10.1016/j.micinf.2021.104840. Epub 2021 May 20.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line
  • Coronavirus* / drug effects
  • Coronavirus* / physiology
  • HIV Fusion Inhibitors
  • HIV-1 / physiology*
  • Humans
  • Lipopeptides / chemistry
  • Lipopeptides / pharmacology*
  • Viral Fusion Proteins / antagonists & inhibitors*
  • Virus Attachment / drug effects*
  • Virus Internalization / drug effects*

Substances

  • HIV Fusion Inhibitors
  • Lipopeptides
  • Viral Fusion Proteins